Exchange: NASDAQ·Updated 06:47 PM EDT
News
all
press releases
Theratechnologies Stock Soars On Acquisition Bid From Future Pak: Retail’s Overjoyed
Future Pak’s proposal offers a cash consideration of $3.51 to $4.50 per share, implying a premium of 164% to 238% on Theratechnologies’ closing price of $1.33 on Thursday.
Stocktwits
Theratechnologies Stock Plummets On Disappointing Q1 Earnings, Full Year Forecast: Retail Sentiment Sours
For the fiscal year 2025, the company estimates revenue in the range of $80 million to $83 million and adjusted EBITDA to be between $10 and $12 million.
Stocktwits

Advertisement|Remove ads.